CONSTRUCTION AND CHARACTERIZATION OF A VI-POSITIVE VARIANT OF THE SALMONELLA-TYPHI LIVE ORAL VACCINE STRAIN TY21A

被引：17
|
作者：
CRYZ, SJ [1 ]
FURER, E [1 ]
BARON, LS [1 ]
NOON, KF [1 ]
RUBIN, FA [1 ]
KOPECKO, DJ [1 ]
机构：
[1] WALTER REED ARMY MED CTR, WASHINGTON, DC 20307 USA
来源：
INFECTION AND IMMUNITY | 1989年 / 57卷 / 12期
关键词：
D O I：
10.1128/IAI.57.12.3863-3868.1989
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3863 / 3868
页数：6
相关论文
共 50 条
  • [31] Use of the α-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain
    Gentschev, I
    Dietrich, G
    Spreng, S
    Neuhaus, B
    Maier, E
    Benz, R
    Goebel, W
    Fensterle, J
    Rapp, UR
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 (06) : 363 - 371
  • [32] EFFICACY OF ONE OR 2 DOSES OF TY21A SALMONELLA-TYPHI VACCINE IN ENTERIC-COATED CAPSULES IN A CONTROLLED FIELD TRIAL
    BLACK, RE
    LEVINE, MM
    FERRECCIO, C
    CLEMENTS, ML
    LANATA, C
    ROONEY, J
    GERMANIER, R
    VACCINE, 1990, 8 (01) : 81 - 84
  • [33] A CONTROLLED FIELD TRIAL OF LIVE ORAL TYPHOID VACCINE TY21A
    WAHDAN, MH
    SERIE, C
    GERMANIER, R
    LACKANY, A
    CERISIER, Y
    GUERIN, N
    SALLAM, S
    GEOFFROY, P
    SADEKELTANTAWI, A
    GUESRY, P
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1980, 58 (03): : 469 - 474
  • [34] Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery
    Dharmasena, Madushini N.
    Feuille, Catherine M.
    Starke, Carly Elizabeth C.
    Bhagwat, Arvind A.
    Stibitz, Scott
    Kopecko, Dennis J.
    PLOS ONE, 2016, 11 (09):
  • [35] Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli
    Hotz, Christian
    Fensterle, Joachim
    Goebel, Werner
    Meyer, Susanne R.
    Kirchgraber, Gabriel
    Heisig, Martin
    Fuerer, Andreas
    Dietrich, Guido
    Rapp, Ulf R.
    Gentschev, Ivaylo
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 (02) : 109 - 119
  • [36] Live oral typhoid vaccine Salmonella Typhi Ty21a-A surrogate vaccine against non-typhoid salmonella?
    Kantele, Anu
    Pakkanen, Sari H.
    Siitonen, Anja
    Karttunen, Riitta
    Kantele, Jussi M.
    VACCINE, 2012, 30 (50) : 7238 - 7245
  • [37] THE IMMUNE-RESPONSE TO TY21A, A LIVE ORAL TYPHOID VACCINE
    BARTHOLOMEUSZ, RCA
    LABROOY, JT
    JOHNSON, M
    SHEARMAN, DJC
    ROWLEY, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (01): : 114 - 114
  • [38] IMPAIRMENT OF IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A DUE TO PREEXISTING CROSS-REACTING INTESTINAL ANTIBODIES
    FORREST, BD
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01): : 210 - 212
  • [39] CONSTRUCTION OF A RECOMBINANT ORAL VACCINE AGAINST SALMONELLA-TYPHI AND SALMONELLA-TYPHIMURIUM
    CAO, YX
    WEN, ZR
    LU, DR
    INFECTION AND IMMUNITY, 1992, 60 (07) : 2823 - 2827
  • [40] SAFETY AND IMMUNOGENICITY OF A LIVE ORAL BIVALENT TYPHOID-FEVER (SALMONELLA-TYPHI TY21A) CHOLERA (VIBRIO-CHOLERAE CVD 103-HGR) VACCINE IN HEALTHY-ADULTS
    CRYZ, SJ
    QUE, JU
    LEVINE, MM
    WIEDERMANN, G
    KOLLARITSCH, H
    INFECTION AND IMMUNITY, 1995, 63 (04) : 1336 - 1339
12345